ALGS Aligos Therapeutics, Inc.
$4.92▲ +3.80%
Healthcare
Other
Volume 14.8K
Avg Volume (10D) 35.4K
Key Metrics & Fundamentals
Market Cap
$30.72M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.98 - 13.69
% vs 50 MA
-16.33%
% vs 200 MA
-24.76%
RSI-14
36.4
MACD Histogram
-0.0400
Beta (1Y vs SPY)
1.42
Free Cash Flow
-$24.95M
Gross Rev
$27.78M
Gross Profit
$27.78M
EBITDA
-$4.14M
COGS
–
Operating Exp
$29.67M
Operating Income
-$1.89M
EBIT
-$1.89M
Pretax Income
$1.31M
Net Income
-$1.50M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
GlobeNewswire · Oct 5, 2026 4:05 PM ET
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
GlobeNewswire · Sep 2, 2026 8:00 AM ET
Aligos Therapeutics Shares Rise 7.6% Premarket Following Recent Company Updates
InvestorsHub · Sep 2, 2026 6:45 AM ET
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
GlobeNewswire · Aug 12, 2026 4:05 PM ET
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
GlobeNewswire · Aug 6, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ALGS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.